Tao Y, Tian C, Qi S, Jia Z, Xu Z, Meng J
Nat Cancer. 2025; .
PMID: 40075237
DOI: 10.1038/s43018-025-00930-5.
Dollinger E, Hernandez-Davies J, Felgner J, Jain A, Hwang M, Strahsburger E
Immunohorizons. 2025; 9(2).
PMID: 39849993
PMC: 11841980.
DOI: 10.1093/immhor/vlae007.
Peng Z, Zhang H, Hu H
Adv Exp Med Biol. 2024; 1466:135-159.
PMID: 39546141
DOI: 10.1007/978-981-97-7288-9_10.
Dabbah-Krancher G, Ruchinskas A, Kallarakal M, Lee K, Bauman B, Epstein B
Eur J Immunol. 2024; 54(12):e2451245.
PMID: 39359035
PMC: 11631677.
DOI: 10.1002/eji.202451245.
Layzell S, Barbarulo A, van Loo G, Beyaert R, Seddon B
Cell Death Differ. 2024; 32(2):256-270.
PMID: 39327505
PMC: 11802744.
DOI: 10.1038/s41418-024-01383-6.
Somatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunity.
Mukohara F, Iwata K, Ishino T, Inozume T, Nagasaki J, Ueda Y
Proc Natl Acad Sci U S A. 2024; 121(35):e2320189121.
PMID: 39167601
PMC: 11363295.
DOI: 10.1073/pnas.2320189121.
PRRSV utilizes MALT1-regulated autophagy flux to switch virus spread and reserve.
Gu H, Qiu H, Yang H, Deng Z, Zhang S, Du L
Autophagy. 2024; 20(12):2697-2718.
PMID: 39081059
PMC: 11587858.
DOI: 10.1080/15548627.2024.2386195.
Insights into mechanisms of MALT1 allostery from NMR and AlphaFold dynamic analyses.
Wallerstein J, Han X, Levkovets M, Lesovoy D, Malmodin D, Mirabello C
Commun Biol. 2024; 7(1):868.
PMID: 39014105
PMC: 11252132.
DOI: 10.1038/s42003-024-06558-y.
MALT1 substrate cleavage: what is it good for?.
Moud B, Ober F, ONeill T, Krappmann D
Front Immunol. 2024; 15:1412347.
PMID: 38863711
PMC: 11165066.
DOI: 10.3389/fimmu.2024.1412347.
Halting multiple myeloma with MALT1 inhibition: suppressing BCMA-induced NF-κB and inducing immunogenic cell death.
Yao Y, Yuan M, Shi M, Li W, Sha Y, Zhang Y
Blood Adv. 2024; 8(15):4003-4016.
PMID: 38820414
PMC: 11339052.
DOI: 10.1182/bloodadvances.2023012394.
Mechanism study of ubiquitination in T cell development and autoimmune disease.
Yu H, Yang W, Cao M, Lei Q, Yuan R, Xu H
Front Immunol. 2024; 15:1359933.
PMID: 38562929
PMC: 10982411.
DOI: 10.3389/fimmu.2024.1359933.
Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma.
Plotnik J, Richardson A, Yang H, Rojas E, Bontcheva V, Dowell C
Mol Cancer Ther. 2024; 23(7):949-960.
PMID: 38507740
PMC: 11217731.
DOI: 10.1158/1535-7163.MCT-23-0518.
Identification of Tensin-3 as a MALT1 substrate that controls B cell adhesion and lymphoma dissemination.
Juilland M, Alouche N, Ubezzi I, Gonzalez M, Rashid H, Scarpellino L
Proc Natl Acad Sci U S A. 2023; 120(52):e2301155120.
PMID: 38109544
PMC: 10756297.
DOI: 10.1073/pnas.2301155120.
Pharmacological inhibition of MALT1 (mucosa-associated lymphoid tissue lymphoma translocation protein 1) induces ferroptosis in vascular smooth muscle cells.
Yan B, Belke D, Gui Y, Chen Y, Jiang Z, Zheng X
Cell Death Discov. 2023; 9(1):456.
PMID: 38097554
PMC: 10721807.
DOI: 10.1038/s41420-023-01748-9.
Unrestrained cleavage of Roquin-1 by MALT1 induces spontaneous T cell activation and the development of autoimmunity.
Schmidt H, Raj T, ONeill T, Muschaweckh A, Giesert F, Negraschus A
Proc Natl Acad Sci U S A. 2023; 120(48):e2309205120.
PMID: 37988467
PMC: 10691344.
DOI: 10.1073/pnas.2309205120.
Deubiquitylating Enzymes in Cancer and Immunity.
Ren J, Yu P, Liu S, Li R, Niu X, Chen Y
Adv Sci (Weinh). 2023; 10(36):e2303807.
PMID: 37888853
PMC: 10754134.
DOI: 10.1002/advs.202303807.
A Model of iPSC-Derived Macrophages with Overexpression Reveals the Peculiarities of TNFAIP3 Protein Expression and Function in Human Macrophages.
Sheveleva O, Protasova E, Nenasheva T, Butorina N, Melnikova V, Gerasimova T
Int J Mol Sci. 2023; 24(16).
PMID: 37629049
PMC: 10454046.
DOI: 10.3390/ijms241612868.
Oncogene-induced MALT1 protease activity drives posttranscriptional gene expression in malignant lymphomas.
Wimberger N, Ober F, Avar G, Grau M, Xu W, Lenz G
Blood. 2023; 142(23):1985-2001.
PMID: 37623434
PMC: 10733837.
DOI: 10.1182/blood.2023021299.
MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas.
Minderman M, Lantermans H, Gruneberg L, Cillessen S, Bende R, van Noesel C
Blood Cancer J. 2023; 13(1):37.
PMID: 36922488
PMC: 10017792.
DOI: 10.1038/s41408-023-00809-7.
Targeting tumor exosomal circular RNA cSERPINE2 suppresses breast cancer progression by modulating MALT1-NF-????B-IL-6 axis of tumor-associated macrophages.
Zhou B, Mo Z, Lai G, Chen X, Li R, Wu R
J Exp Clin Cancer Res. 2023; 42(1):48.
PMID: 36797769
PMC: 9936722.
DOI: 10.1186/s13046-023-02620-5.